Does the media prefer HNGE or PRVA?

In the previous week, Hinge Health had 8 more articles in the media than Privia Health Group. MarketBeat recorded 9 mentions for Hinge Health and 1 mentions for Privia Health Group. Privia Health Group's average media sentiment score of 0.81 beat Hinge Health's score of 0.57 indicating that Privia Health Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Hinge Health 2 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Privia Health Group 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better earnings & valuation, CHE or PRVA?

Chemed has higher revenue and earnings than Privia Health Group. Chemed is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Chemed $2.53B 2.59 $265.24M $19.91 25.23 Privia Health Group $2.12B 1.21 $22.92M $0.21 95.38

Does the media prefer CHE or PRVA?

In the previous week, Chemed had 11 more articles in the media than Privia Health Group. MarketBeat recorded 12 mentions for Chemed and 1 mentions for Privia Health Group. Privia Health Group's average media sentiment score of 0.81 beat Chemed's score of 0.13 indicating that Privia Health Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Chemed 2 Very Positive mention(s) 0 Positive mention(s) 9 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Privia Health Group 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor PRVA or HIMS?

In the previous week, Hims & Hers Health had 45 more articles in the media than Privia Health Group. MarketBeat recorded 46 mentions for Hims & Hers Health and 1 mentions for Privia Health Group. Privia Health Group's average media sentiment score of 0.81 beat Hims & Hers Health's score of 0.07 indicating that Privia Health Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Privia Health Group 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Hims & Hers Health 2 Very Positive mention(s) 5 Positive mention(s) 38 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer BLLN or PRVA?

In the previous week, Billiontoone had 13 more articles in the media than Privia Health Group. MarketBeat recorded 14 mentions for Billiontoone and 1 mentions for Privia Health Group. Privia Health Group's average media sentiment score of 0.81 beat Billiontoone's score of 0.22 indicating that Privia Health Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Billiontoone 5 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Privia Health Group 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer RDNT or PRVA?

In the previous week, RadNet had 4 more articles in the media than Privia Health Group. MarketBeat recorded 5 mentions for RadNet and 1 mentions for Privia Health Group. Privia Health Group's average media sentiment score of 0.81 beat RadNet's score of 0.51 indicating that Privia Health Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment RadNet 1 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Privia Health Group 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Privia Health Group (PRVA) Competitors

$20.03 +0.34 (+1.73%)

Closing price 10/1/2026 04:00 PM Eastern

Extended Trading

$20.02 -0.01 (-0.02%)

As of 10/1/2026 07:30 PM Eastern

Compare

PRVA vs. HNGE, CHE, HIMS, BLLN, and RDNT

Should you buy Privia Health Group stock or one of its competitors? Privia Health Group's main competitors and comparable companies include Hinge Health (HNGE), Chemed (CHE), Hims & Hers Health (HIMS), Billiontoone (BLLN), and RadNet (RDNT). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does Privia Health Group compare to Hinge Health?

Hinge Health (NYSE:HNGE) and Privia Health Group (NASDAQ:PRVA) are both mid-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, risk, dividends, media sentiment, profitability, valuation, earnings and institutional ownership.

In the previous week, Hinge Health had 8 more articles in the media than Privia Health Group. MarketBeat recorded 9 mentions for Hinge Health and 1 mentions for Privia Health Group. Privia Health Group's average media sentiment score of 0.81 beat Hinge Health's score of 0.57 indicating that Privia Health Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Hinge Health	2 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Privia Health Group	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

94.5% of Privia Health Group shares are owned by institutional investors. 18.9% of Hinge Health shares are owned by insiders. Comparatively, 5.7% of Privia Health Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Privia Health Group has higher revenue and earnings than Hinge Health. Hinge Health is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hinge Health	$587.86M	13.39	-$528.26M	$1.28	76.23
Privia Health Group	$2.12B	1.21	$22.92M	$0.21	95.38

Hinge Health has a beta of 1.37, meaning that its share price is 37% more volatile than the broader market. Comparatively, Privia Health Group has a beta of 0.8, meaning that its share price is 20% less volatile than the broader market.

Hinge Health presently has a consensus price target of $105.33, suggesting a potential upside of 7.95%. Privia Health Group has a consensus price target of $31.00, suggesting a potential upside of 54.77%. Given Privia Health Group's higher possible upside, analysts plainly believe Privia Health Group is more favorable than Hinge Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hinge Health	0 Sell rating(s)	3 Hold rating(s)	15 Buy rating(s)	1 Strong Buy rating(s)	2.89
Privia Health Group	0 Sell rating(s)	3 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.79

Hinge Health has a net margin of 15.15% compared to Privia Health Group's net margin of 1.19%. Hinge Health's return on equity of 51.60% beat Privia Health Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hinge Health	15.15%	51.60%	14.16%
Privia Health Group	1.19%	3.52%	2.00%

Summary

Hinge Health beats Privia Health Group on 11 of the 17 factors compared between the two stocks.

How does Privia Health Group compare to Chemed?

Chemed (NYSE:CHE) and Privia Health Group (NASDAQ:PRVA) are both mid-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, risk, profitability, earnings, institutional ownership, valuation, media sentiment and dividends.

Chemed has a net margin of 10.60% compared to Privia Health Group's net margin of 1.19%. Chemed's return on equity of 31.77% beat Privia Health Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Chemed	10.60%	31.77%	18.90%
Privia Health Group	1.19%	3.52%	2.00%

Chemed has a beta of 0.51, meaning that its stock price is 49% less volatile than the broader market. Comparatively, Privia Health Group has a beta of 0.8, meaning that its stock price is 20% less volatile than the broader market.

95.9% of Chemed shares are owned by institutional investors. Comparatively, 94.5% of Privia Health Group shares are owned by institutional investors. 3.3% of Chemed shares are owned by company insiders. Comparatively, 5.7% of Privia Health Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Chemed has higher revenue and earnings than Privia Health Group. Chemed is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Chemed	$2.53B	2.59	$265.24M	$19.91	25.23
Privia Health Group	$2.12B	1.21	$22.92M	$0.21	95.38

In the previous week, Chemed had 11 more articles in the media than Privia Health Group. MarketBeat recorded 12 mentions for Chemed and 1 mentions for Privia Health Group. Privia Health Group's average media sentiment score of 0.81 beat Chemed's score of 0.13 indicating that Privia Health Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Chemed	2 Very Positive mention(s)	0 Positive mention(s)	9 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Privia Health Group	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Chemed currently has a consensus target price of $554.60, suggesting a potential upside of 10.41%. Privia Health Group has a consensus target price of $31.00, suggesting a potential upside of 54.77%. Given Privia Health Group's stronger consensus rating and higher probable upside, analysts clearly believe Privia Health Group is more favorable than Chemed.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Chemed	0 Sell rating(s)	5 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.29
Privia Health Group	0 Sell rating(s)	3 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.79

Summary

Chemed beats Privia Health Group on 9 of the 16 factors compared between the two stocks.

How does Privia Health Group compare to Hims & Hers Health?

Privia Health Group (NASDAQ:PRVA) and Hims & Hers Health (NYSE:HIMS) are both mid-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, risk, profitability, media sentiment, valuation, analyst recommendations, dividends and institutional ownership.

Privia Health Group presently has a consensus target price of $31.00, indicating a potential upside of 54.77%. Hims & Hers Health has a consensus target price of $32.43, indicating a potential upside of 10.80%. Given Privia Health Group's stronger consensus rating and higher probable upside, research analysts plainly believe Privia Health Group is more favorable than Hims & Hers Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Privia Health Group	0 Sell rating(s)	3 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.79
Hims & Hers Health	1 Sell rating(s)	12 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.13

Hims & Hers Health has higher revenue and earnings than Privia Health Group. Hims & Hers Health is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Privia Health Group	$2.12B	1.21	$22.92M	$0.21	95.38
Hims & Hers Health	$2.35B	2.91	$128.37M	-$0.63	N/A

94.5% of Privia Health Group shares are owned by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are owned by institutional investors. 5.7% of Privia Health Group shares are owned by company insiders. Comparatively, 11.8% of Hims & Hers Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Privia Health Group has a net margin of 1.19% compared to Hims & Hers Health's net margin of -5.51%. Privia Health Group's return on equity of 3.52% beat Hims & Hers Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Privia Health Group	1.19%	3.52%	2.00%
Hims & Hers Health	-5.51%	-6.51%	-1.20%

Privia Health Group has a beta of 0.8, meaning that its stock price is 20% less volatile than the broader market. Comparatively, Hims & Hers Health has a beta of 2.44, meaning that its stock price is 144% more volatile than the broader market.

In the previous week, Hims & Hers Health had 45 more articles in the media than Privia Health Group. MarketBeat recorded 46 mentions for Hims & Hers Health and 1 mentions for Privia Health Group. Privia Health Group's average media sentiment score of 0.81 beat Hims & Hers Health's score of 0.07 indicating that Privia Health Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Privia Health Group	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Hims & Hers Health	2 Very Positive mention(s)	5 Positive mention(s)	38 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Privia Health Group beats Hims & Hers Health on 10 of the 16 factors compared between the two stocks.

How does Privia Health Group compare to Billiontoone?

Billiontoone (NASDAQ:BLLN) and Privia Health Group (NASDAQ:PRVA) are both mid-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, institutional ownership, analyst recommendations, risk, valuation, media sentiment, dividends and profitability.

Privia Health Group has higher revenue and earnings than Billiontoone. Privia Health Group is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Billiontoone	$305.11M	16.36	$7.45M	$0.70	151.09
Privia Health Group	$2.12B	1.21	$22.92M	$0.21	95.38

Billiontoone has a net margin of 8.04% compared to Privia Health Group's net margin of 1.19%. Billiontoone's return on equity of 9.96% beat Privia Health Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Billiontoone	8.04%	9.96%	5.35%
Privia Health Group	1.19%	3.52%	2.00%

94.5% of Privia Health Group shares are held by institutional investors. 50.2% of Billiontoone shares are held by company insiders. Comparatively, 5.7% of Privia Health Group shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, Billiontoone had 13 more articles in the media than Privia Health Group. MarketBeat recorded 14 mentions for Billiontoone and 1 mentions for Privia Health Group. Privia Health Group's average media sentiment score of 0.81 beat Billiontoone's score of 0.22 indicating that Privia Health Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Billiontoone	5 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Privia Health Group	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Billiontoone currently has a consensus target price of $126.25, indicating a potential upside of 19.37%. Privia Health Group has a consensus target price of $31.00, indicating a potential upside of 54.77%. Given Privia Health Group's stronger consensus rating and higher possible upside, analysts plainly believe Privia Health Group is more favorable than Billiontoone.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Billiontoone	2 Sell rating(s)	2 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.45
Privia Health Group	0 Sell rating(s)	3 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.79

Summary

Billiontoone beats Privia Health Group on 8 of the 15 factors compared between the two stocks.

How does Privia Health Group compare to RadNet?

RadNet (NASDAQ:RDNT) and Privia Health Group (NASDAQ:PRVA) are both mid-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, dividends, earnings, analyst recommendations, profitability, institutional ownership, valuation and risk.

Privia Health Group has higher revenue and earnings than RadNet. RadNet is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
RadNet	$2.04B	2.61	-$18.65M	-$0.27	N/A
Privia Health Group	$2.12B	1.21	$22.92M	$0.21	95.38

RadNet has a beta of 1.41, meaning that its stock price is 41% more volatile than the broader market. Comparatively, Privia Health Group has a beta of 0.8, meaning that its stock price is 20% less volatile than the broader market.

77.9% of RadNet shares are held by institutional investors. Comparatively, 94.5% of Privia Health Group shares are held by institutional investors. 5.1% of RadNet shares are held by insiders. Comparatively, 5.7% of Privia Health Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Privia Health Group has a net margin of 1.19% compared to RadNet's net margin of -0.93%. Privia Health Group's return on equity of 3.52% beat RadNet's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
RadNet	-0.93%	2.61%	0.91%
Privia Health Group	1.19%	3.52%	2.00%

RadNet presently has a consensus price target of $90.00, suggesting a potential upside of 32.94%. Privia Health Group has a consensus price target of $31.00, suggesting a potential upside of 54.77%. Given Privia Health Group's higher possible upside, analysts clearly believe Privia Health Group is more favorable than RadNet.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
RadNet	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	2 Strong Buy rating(s)	2.89
Privia Health Group	0 Sell rating(s)	3 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.79

In the previous week, RadNet had 4 more articles in the media than Privia Health Group. MarketBeat recorded 5 mentions for RadNet and 1 mentions for Privia Health Group. Privia Health Group's average media sentiment score of 0.81 beat RadNet's score of 0.51 indicating that Privia Health Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
RadNet	1 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Privia Health Group	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Privia Health Group beats RadNet on 12 of the 17 factors compared between the two stocks.

Get Privia Health Group News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PRVA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

PRVA vs. The Competition

Export

Metric	Privia Health Group	Healthcare Providers & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$2.52B	$9.59B	$7.23B	$13.08B
Dividend Yield	N/A	2.60%	2.53%	15.88%
P/E Ratio	95.39	33.84	272.66	25.80
Price / Sales	1.21	4.89	607.38	90.99
Price / Cash	73.78	120.27	77.38	51.29
Price / Book	3.12	5.12	11.09	6.26
Net Income	$22.92M	$315.68M	$3.50B	$360.95M
7 Day Performance	1.62%	-3.31%	-2.02%	-1.81%
1 Month Performance	-3.33%	-3.25%	-6.43%	-4.03%
1 Year Performance	-18.11%	7.93%	8.98%	2.18%

Privia Health Group Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
PRVA Privia Health Group	4.6959 of 5 stars	$20.03 +1.7%	$31.00 +54.8%	-19.8%	$2.52B	$2.12B	95.39	1,226	Analyst Forecast
HNGE Hinge Health	3.3582 of 5 stars	$95.10 +2.9%	$104.13 +9.5%	+100.1%	$7.65B	$587.86M	74.04	1,437	Analyst Forecast
CHE Chemed	3.3054 of 5 stars	$513.42 -0.2%	$554.60 +8.0%	+14.1%	$6.71B	$2.53B	25.78	15,811	Insider Trade
HIMS Hims & Hers Health	2.1162 of 5 stars	$28.62 -0.6%	$32.43 +13.3%	-48.0%	$6.69B	$2.35B	N/A	2,442	Trending News
BLLN Billiontoone	3.5975 of 5 stars	$119.32 -2.0%	$125.88 +5.5%	N/A	$5.74B	$397.41M	170.46	713	Analyst Forecast Insider Trade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:PRVA) was last updated on 10/2/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Privia Health Group (PRVA) Competitors

PRVA vs. HNGE, CHE, HIMS, BLLN, and RDNT

How does Privia Health Group compare to Hinge Health?

Summary

How does Privia Health Group compare to Chemed?

Summary

How does Privia Health Group compare to Hims & Hers Health?

Summary

How does Privia Health Group compare to Billiontoone?

Summary

How does Privia Health Group compare to RadNet?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PRVA vs. The Competition

Privia Health Group Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Privia Health Group (PRVA) Competitors

PRVA vs. HNGE, CHE, HIMS, BLLN, and RDNT

How does Privia Health Group compare to Hinge Health?

Does the media prefer HNGE or PRVA?

Do institutionals & insiders hold more shares of HNGE or PRVA?

Which has stronger earnings and valuation, HNGE or PRVA?

Which has more volatility and risk, HNGE or PRVA?

Do analysts rate HNGE or PRVA?

Is HNGE or PRVA more profitable?

Summary

How does Privia Health Group compare to Chemed?

Is CHE or PRVA more profitable?

Which has more risk & volatility, CHE or PRVA?

Do institutionals and insiders hold more shares of CHE or PRVA?

Which has better earnings & valuation, CHE or PRVA?

Does the media prefer CHE or PRVA?

Do analysts rate CHE or PRVA?

Summary

How does Privia Health Group compare to Hims & Hers Health?

Do analysts prefer PRVA or HIMS?

Which has stronger earnings and valuation, PRVA or HIMS?

Do institutionals & insiders have more ownership in PRVA or HIMS?

Is PRVA or HIMS more profitable?

Which has more risk & volatility, PRVA or HIMS?

Does the media favor PRVA or HIMS?

Summary

How does Privia Health Group compare to Billiontoone?

Which has better valuation and earnings, BLLN or PRVA?

Is BLLN or PRVA more profitable?

Do insiders and institutionals believe in BLLN or PRVA?

Does the media prefer BLLN or PRVA?

Do analysts prefer BLLN or PRVA?

Summary

How does Privia Health Group compare to RadNet?

Which has higher earnings and valuation, RDNT or PRVA?

Which has more volatility & risk, RDNT or PRVA?

Do institutionals & insiders hold more shares of RDNT or PRVA?

Is RDNT or PRVA more profitable?

Do analysts recommend RDNT or PRVA?

Does the media prefer RDNT or PRVA?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PRVA vs. The Competition

Privia Health Group Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools